75726 Federal Register / Vol. 65, No. 233 / Monday, December 4, 2000 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental &

Craniofacial Research; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, National

Institute of Dental and Craniofacial

Research.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Institute of Dental &

Craniofacial Research, including

consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Institute of Dental and

Craniofacial Research, Gene Therapy &

Therapeutics & Molecular Structural Biology

Section.

Date: December 7–8, 2000.

Closed: December 7, 2000, 8:30 a.m. to 9

a.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: NIH, Building 30, Room 132,

Bethesda, MD 20892.

Closed: December 7, 2000, 4:20 p.m. to 6

p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: NIH, Building 30, Room 132,

Bethesda, MD 20892.

Open: December 8, 2000, 8:30 a.m. to 11:55

a.m.

Agenda: Laboratory Tours, Poster

Presentations.

Place: NIH, Building 30, Room 132,

Bethesda, MD 20892.

Closed: December 8, 2000, 12:05 p.m. to

4:30 p.m.

Agenda: To review and evaluate meeting

Report Formulation, Exit Interviews.

Place: NIH, Building 30, Room 132,

Bethesda, MD 20892.

Contact Person: Wendy A. Liffers, JD,

Director, Office of Science Policy & Analysis,

National Institute of Dental & Craniofacial

Res., 31 Center Drive, Rm. 5B55, Bethesda,

MD 20892–2190.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the intramural research review cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: November 22, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30709 Filed 12–1–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: December 18, 2000.

Time: 12 to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Center Drive, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: John R. Lymangrover,

Scientific Review Administrator, National

Institutes of Health, NIAMS, Natcher Bldg.,

Room 5As25N, Bethesda, MD 20892, 301–

594–4952.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: December 20, 2000.

Time: 2 to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Natcher Bldg., Rm 5As.25u,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Tracy A. Shahan,

Scientific Review Administrator, National

Institutes of Health, NIAMS, Natcher Bldg.,

Room 5AS25H, Bethesda, MD 20892, 301–

594–4952.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: November 22, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–30710 Filed 12–1–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Toxicology Program; National

Toxicology Program (NTP) Board of

Scientific Counselors Meeting; Review

of Nominations for Listing in the 10th

Report on Carcinogens: Revised

Preliminary Agenda and Review Order

This notice provides updated

information and notes changes for the

meeting of the NTP Board of Scientific

Counselors’ Report on Carcinogens

(RoC) Subcommittee to be held on

December 13, 14, & 15, 2000, at the

Wyndham City Center, 1143 New

Hampshire Ave., NW, Washington, DC

20037. On December 13, registration

will begin at 9:00 am and the meeting

will begin at 9:30 am. On December 14

& 15, the meeting will begin at 8:30 am.

Pre-registration is not required;

however, persons requesting time to

make oral, public comments are asked

to notify Dr. Mary S. Wolfe, Executive

Secretary, prior to the meeting (contact

information given below).

Background

This meeting covers the peer review

of nominations for listing in the 10th

RoC, and includes opportunity for

public input. An earlier notice of this

meeting, which included information

about the nominations, review order,

solicitation of oral and written

comments, and how to secure

background documents for the

nominations, was published in the

Federal Register (October 17, 2000,

Volume 65, Number 201, Pages 61352–

61354).

Changes in Review Order

While the agenda for this meeting

remains preliminary, the order of the

review as published in the previous

notice has been altered as follows: the

review of Chloramphenicol changes

from six to five; Talc (Asbestiform and